Latest Updates & News
A New Era in Lung Cancer Treatment: FDA Approves Augtyro on November 15, 2023
What is Augtyro prescribed for? Augtyro is prescribed for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer. What is Augtyro and what does it do? Augtyro, pronounced Aug-TYE-ro, (generic name: repotrectinib) is a newly FDA-approved medication for treating a specific type of lung cancer called...
How Benzodiazepine Use for Anxiety May Increase Your Risk of Dementia: What You Need to Know
What Did the Research Discover? Researchers studied whether benzodiazepine use is linked to a higher risk of dementia or cognitive decline in older adults. The study followed 3,434 participants aged 65 and older in Seattle, Washington, who did not have dementia at the beginning of the study. They were observed for an average of 7.3 years, with cognitive tests given...
Breakthrough Blood Test May Predict Parkinson’s Disease Earlier
What did the research discover? Parkinson’s disease is becoming more common and progresses from a pre-motor stage, where early non-motor symptoms like REM sleep behavior disorder appear, to the more disabling motor stage. Detecting the disease early is critical to slowing its progression, but there is currently no reliable biomarker for early diagnosis. This study...
New Potential Treatment for Severe Depression Shows Promise
What did the research discover? Researchers tested a new treatment for depression called Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). This treatment uses intermittent theta-burst stimulation (iTBS), a type of brain stimulation already approved by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression. SAINT was designed...
Smart Speaker Therapy Helps Breast Cancer Survivors Sleep Better
What did the research discover? Researchers tested if a voice-activated therapy using cognitive behavioral therapy for insomnia (CBT-I) could help breast cancer survivors who have trouble sleeping. CBT-I is a type of talk therapy that teaches ways to improve sleep by changing habits and thoughts that make it hard to rest. This therapy was delivered through a smart...
FDA Update: New Tool Shows Chemical Contaminant Levels in Food for Greater Transparency
For Immediate Release: March 20, 2025 Today, under the leadership of U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr., the U.S. Food and Drug Administration unveiled the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database providing a consolidated list of contaminant levels (e.g., tolerances, action levels,...
FDA Update: New Kidney Drug Approved, Medical Device Alert Issued, and Colonoscopy Cleaner AuthorizedFDA Roundup: March 21, 2025
For Immediate Release: March 21, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G) to reduce proteinuria. C3G is a rare disease that causes inflammation and damage to the kidney...